covid-19

Showing NaN - NaN of 67

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, SARS-CoV-2 Infection Trial in United States (AZD9838, Licensed mRNA vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • AZD9838
  • Licensed mRNA vaccine
  • Long Beach, California
  • +4 more
Nov 24, 2023

COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)

Active, not recruiting
  • COVID-19
  • Experimental: Primary Cohort
  • Placebo Comparator: Primary Cohort - Placebo
  • Chicago, Illinois
    University of Chicago
Aug 24, 2023

Rheumatic Diseases, COVID-19 Vaccine, COVID-19 Trial in Chicago (COVID-19 vaccine and booster training, and importance)

Not yet recruiting
  • Rheumatic Diseases
  • +3 more
  • COVID-19 vaccine and booster training, and importance
  • Chicago, Illinois
    Northwestern University
Apr 7, 2023

COVID-19 Trial in Canada, United Kingdom, United States (mRNA-1283.222, mRNA-1273.222)

Recruiting
  • COVID-19
  • mRNA-1283.222
  • mRNA-1273.222
  • Birmingham, Alabama
  • +209 more
Apr 13, 2023

COVID-19 Trial in Chicago, Ann Arbor (Azeliragon, Placebo)

Recruiting
  • COVID-19
  • Chicago, Illinois
  • +1 more
Apr 13, 2023

COVID-19 Trial in United States (drug, biological, other)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +21 more
Feb 2, 2023

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

COVID-19 Trial in Worldwide (AZD7442, Placebo)

Completed
  • COVID-19
  • Jasper, Alabama
  • +102 more
Jan 14, 2023

COVID-19 Trial in Worldwide (ensovibep, Placebo)

Terminated
  • COVID-19
  • Jasper, Alabama
  • +47 more
Dec 21, 2022

COVID-19 Trial in Worldwide (AZD7442, Placebo)

Active, not recruiting
  • COVID-19
  • Birmingham, Alabama
  • +85 more
Nov 25, 2022

COVID-19 Trial in United States (other, drug, biological)

Completed
  • COVID-19
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +31 more
Nov 23, 2022

COVID-19 Trial in Worldwide (ADG20, Placebo)

Terminated
  • COVID-19
  • Birmingham, Alabama
  • +94 more
Nov 22, 2022

COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)

Completed
  • COVID-19
  • +2 more
  • pathogen reduced SARS-CoV-2 convalescent plasma
  • Placebo
  • Little Rock, Arkansas
  • +25 more
Oct 6, 2022

Long Term Outcomes of Patients With COVID-19

Active, not recruiting
  • Critical Illness
  • +3 more
  • Quality of Life
  • +2 more
  • Chicago, Illinois
    University of Chicago Medical Center
Nov 1, 2022

COVID-19 Trial in United Kingdom, United States (AZD7442, Placebo)

Completed
  • COVID-19
  • Guntersville, Alabama
  • +56 more
Oct 24, 2022

Infection Viral, Thromboses, Venous, COVID-19 Trial in United States (Enoxaparin Prefilled Syringe [Lovenox])

Completed
  • Infection Viral
  • +2 more
  • Enoxaparin Prefilled Syringe [Lovenox]
  • Birmingham, Alabama
  • +15 more
Sep 15, 2022

COVID-19, Burnout, Burnout, Professional Trial in Chicago (Positive Affect Regulation sKills (PARK))

Recruiting
  • COVID-19
  • +5 more
  • Positive Affect Regulation sKills (PARK)
  • Chicago, Illinois
    Northwestern University
Sep 28, 2022

SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

Completed
  • SARS-CoV Infection
  • +3 more
  • Moderna COVID-19 Vaccine
  • +2 more
  • Tucson, Arizona
  • +28 more
Sep 19, 2022

COVID-19 Trial in Worldwide (Remdesivir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +36 more
Aug 18, 2022

COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)

Terminated
  • COVID-19
  • SARS-CoV-2
  • Ascorbic Acid
  • +4 more
  • Chicago, Illinois
  • +5 more
Jul 12, 2022

COVID-19 Trial in Worldwide (Tocilizumab)

Recruiting
  • COVID-19
  • Orange, California
  • +13 more
Aug 4, 2022

COVID-19 Trial in Worldwide (nirmatrelvir, ritonavir)

Recruiting
  • COVID-19
  • Birmingham, Alabama
  • +94 more
Aug 2, 2022

COVID-19 Trial in Worldwide (SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent), SARS-CoV-2 adjuvanted recombinant

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent)
  • +2 more
  • Birmingham, Alabama
  • +93 more
Jul 22, 2022

COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)

Completed
  • COVID-19
  • Lenzilumab
  • +2 more
  • Birmingham, Alabama
  • +55 more
Jul 21, 2022